Clinical Trial Update: Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating cholestyramine for managing hyperphosphatemia in adults undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Cholestyramine (cholestyramine)

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Kidney Diseases, Hemodialysis Complication | Phase 4 | Status: COMPLETED